Search Results - terry hinds

3 Results Sort By:
PEGylated Bilirubin for the treatment of Hyperlipidemia, Obesity, and Type II Diabetes
Project ID: D2018-40Background:Obesity, a low-grade inflammatory disease, has affected more than 150 million people in the US. Obesity and its associated risk factors are a prelude to the development of type II diabetes that accounts for a vast majority of the 25.8 million diabetes cases in the US. Bilirubin, a yellow pigment produced during red bl...
“Thin” Molecules for Treating Obesity and Type II Diabetes
Project ID: D2016-29IP Status: PCT patent application filedInvention Description and Novelty: “Thin” molecules offer stronger binding to PPAR and include greater lipid burning and glucose lowering properties. Applications: Dyslipidemia, obesity and type II diabetes Value propositions: • Bilirubin reduces body fat percentage...
“Sweet-P”: Molecule for Targeting Human Glucocorticoid Receptor Beta in Cancer
Project ID: D2016-49Background Glucocorticoids are the most prescribed anti-inflammatory drugs. They are also used in cancer therapies, and for their protective properties against the toxic effects of chemotherapy. Glucocorticoids may, however, cause resistance to platinum-based chemotherapeutics, resulting in the proliferation of cancer cells. The...